Results 81 to 90 of about 26,059 (187)

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS

Рациональная фармакотерапия в кардиологии, 2018
Aim. To perform pharmacoeconomic analysis of CHF therapy with supramolecular sacubitril/valsartan complex compared to routine therapy in patients with diabetes type 2 and ACE inhibitor intolerance within context of Russian healthcare system.Material and ...
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov   +2 more
doaj   +1 more source

A Claims-Based Algorithm for Identifying Hidradenitis Suppurativa Severity

Clinical Epidemiology
Maria C Schneeweiss,1– 3 Priyanka Anand,1,2 Arash Mostaghimi,2,3 Joan Landon,1,2 Denys Shay,1,4 Olivia MT Davies,2,3 Anusha Mohan Kumar,2,3 Aijing Shang,5 Tanja Tran,6 Robert J Glynn,1,2 Kueiyu Joshua Lin,1,2,7,8 Richard Wyss1,2 1Division of ...
Schneeweiss MC, Anand P, Mostaghimi A, Landon J, Shay D, Davies OMT, Kumar AM, Shang A, Tran T, Glynn RJ, Lin KJ, Wyss R   +11 more
doaj  

Ten Healthcare Delivery Trends and Their Measurement and Methodological Implications for Cancer Health Services Research

Health Services Research, Volume 61, Issue 2, April 2026.
Sallie J. Weaver, Sandra A. Mitchell
wiley   +1 more source

Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry

Complexity
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system.
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh   +7 more
doaj   +1 more source

Analysis of the knowledge and skills of physiotherapists and physiotherapy students regarding pulmonary rehabilitation in post-COVID-19 patients

BMC Medical Education
Background Pulmonary rehabilitation plays a crucial role in the recovery of patients after COVID-19. Because training standards and clinical exposure differ internationally, the present findings should be interpreted within the Polish educational and ...
Dorota Kopciuch, Krzysztof Ciosek, Kinga Adamska, Natalia Chojara, Anna Paczkowska, Tomasz Zaprutko, Piotr Ratajczak, Elżbieta Nowakowska, Krzysztof Kus   +8 more
doaj   +1 more source

Cost-effectiveness of Kang Ai injection plus chemotherapy vs. Shenqi Fuzheng injection plus chemotherapy in the first-line treatment of advanced non-small cell lung cancer

Frontiers in Medicine
ObjectiveThis study aimed to evaluate the cost-effectiveness of two Chinese patent medicines, including Kang Ai injection and Shenqi Fuzheng injection with each combined with platinum-based chemotherapy as the first-line treatment for patients with ...
Junjie Zhu, Junjie Zhu, Lei Tian, Lei Tian   +3 more
doaj   +1 more source

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

BMC Cancer
Objectives To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC).
Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang   +4 more
doaj   +1 more source

Anaesthesia pharmacoeconomics [PDF]

Canadian Journal of Anaesthesia, 1993
openaire   +2 more sources

Efficacy and safety of proprotein convertase subtilisin/kexin type 9 inhibitors for adults with familial hypercholesterolemia: A network meta-analysis

International Journal of Cardiology. Cardiovascular Risk and Prevention
Purpose: The comparative efficacy and safety profiles of PCSK9 inhibitors in familial hypercholesterolemia (FH), including genotype-dependent treatment responses, remain unclear.
Weiwei Ding, Lingyao Sun, Yun Shi, Lei Tian   +3 more
doaj   +1 more source

Pharmacoeconomics of chronic kidney disease

Регуляторные исследования и экспертиза лекарственных средств, 2018
A pharmacoeconomic study is a comprehensive scientific and research activity, which should take into account specific characteristics of a research subject as well as nosology based on common methodological approaches of pharmacoeconomics,.
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, G. T. Abdrashitova, M. V. Protsenko   +4 more
doaj